Crotedumab Antibody
Crotedumab (REGN1193) is a humanized anti-GCGR antibody utilized in diabetes research. It functions by antagonizing the glucagon receptor, leading to reduced fasting blood glucose and improved glucose tolerance in preclinical studies, supporting its investigation for metabolic disease therapeutics.
Product Specifications
Product Name Alternative
REGN1193, REGN 1193, Anti-GCGR Reference Antibody
Target
Glucagon Receptor
Conjugation
Unconjugated
Field of Research
Pharmacology & Drug Discovery
Concentration
5.92 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
146.82 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3668904 1.0 µg DNA
Tsnax sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details 
149985 100 µg
DHX58 (Probable ATP-dependent RNA Helicase DHX58, Probable ATP-dependent Helicase LGP2, Protein D11Lgp2 Homolog, RIG-I-like Receptor 3, RLR-3, RIG-I-like Receptor LGP2, RLR, D11LGP2E, LGP2)
Sign In for Pricing
View Details 
127745-ML550 100 µL
HCCS (CCHL, Cytochrome c-type Heme Lyase, Holocytochrome c-type Synthase) (MaxLight 550)
Sign In for Pricing
View Details